Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Accuray Incorporated (ARAY) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 432,980
  • Shares Outstanding, K 81,640
  • Annual Sales, $ 398,800 K
  • Annual Income, $ -25,500 K
  • 36-Month Beta 1.72
  • Price/Sales 1.09
  • Price/Book 8.11

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.45 +14.61%
on 12/27/16
5.40 -5.56%
on 01/17/17
+0.50 (+10.87%)
since 12/23/16
3-Month
4.45 +14.61%
on 12/27/16
5.55 -8.11%
on 10/25/16
-0.25 (-4.67%)
since 10/21/16
52-Week
4.45 +14.61%
on 12/27/16
6.39 -20.19%
on 09/30/16
-0.94 (-15.56%)
since 01/22/16

Most Recent Stories

More News
Accuray to Present at JP Morgan's 35th Annual Healthcare Conference on January 11, 2017

Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will present at JP Morgan's 35th Annual Healthcare Conference on Wednesday, January 11, 2017 at the Westin St. Francis Hotel in San...

Accuray: Hong Kong Sanatorium to Buy 3 Radixact Systems

Accuray Incorporated (ARAY) has signed an agreement with Hong Kong Sanatorium & Hospital per which the latter would purchase three Radixact Systems.

Hong Kong Sanatorium & Hospital to Acquire Three RadixactTM Systems

Accuray Incorporated (NASDAQ: ARAY) has signed an agreement with Hong Kong Sanatorium & Hospital (HKSH) for the acquisition of three RadixactTM Systems that will provide clinicians and their patients with...

Treatment with the TomoTherapy® System Concurrent with Systemic Medication Improves Progression-Free Survival in Patients with Solitary Plasmacytoma of the Bone

SUNNYVALE, California, December 20, 2016 /PRNewswire/ --

Technical Reports on Medical Equipment Stocks -- Globus Medical, ZELTIQ Aesthetics, Accuray, and ABIOMED

Four Medical Appliances and Equipment equities have been selected for evaluation by Stock-Callers.com this morning, and they are Globus Medical Inc. (NYSE: GMED), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ),...

First Cancer Patients in the World Treated with the Smart, New Accuray Radixact(TM) System

SUNNYVALE, California, December 8, 2016 /PRNewswire/ --

First Cancer Patients in the World Treated with the Smart, New Accuray Radixact(TM) System

Accuray Incorporated (NASDAQ: ARAY) announced today that leading hospitals in Europe and the United States are now treating patients with the new Radixact(TM) Treatment Delivery System, fully integrated...

Accuray to Participate in the Citi 2016 Global Healthcare Conference

Accuray Incorporated (Nasdaq: ARAY), announced today that it will participate in the Citi 2016 Global Healthcare Conference on Thursday, December 8, 2016 in New York City. Kevin Waters, Senior Vice President...

Accuray (ARAY) Incurs Wider Loss in Q1, Misses on Revenue

Accuray Inc. (ARAY) reported a loss of 12 cents per share in the first quarter of fiscal 2017, wider than the Zacks Consensus Estimate of a loss of 10 cents.

Why Accuray (ARAY) Isn't Done Growing Earnings Yet

Accuray (ARAY) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Growth perspective.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends...

See More

Support & Resistance

2nd Resistance Point 5.30
1st Resistance Point 5.20
Last Price 5.10
1st Support Level 5.05
2nd Support Level 5.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.